Early detection and invasive passivation of future culprit lesions: A future potential or an unrealistic pursuit of chimeras?

American Heart Journal

Volumn 165, Issue 6, 2013, Pages

  Bourantas, Christos V ^a   Garcia Garcia, Hector M ^a   Diletti, Roberto ^a   Muramatsu, Takashi ^a   Serruys, Patrick W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GADOLINIUM; IODINE 125; TECHNETIUM 99M;

ANGIOSCOPY; ARTICLE; ATHEROSCLEROSIS; BLOOD CLOTTING; BLOOD FLOW; CHIMERA; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; EARLY DIAGNOSIS; FLUORESCENCE SPECTROSCOPY; FOLLOW UP; HUMAN; INFLAMMATION; INTRAVASCULAR ULTRASOUND; MORPHOLOGICAL TRAIT; NEAR INFRARED SPECTROSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PHOTOACOUSTICS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAMAN SPECTROMETRY; SIGNAL PROCESSING; THERMOGRAPHY;

EID: 84880063070     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2013.02.015     Document Type: Review

References (112)

1. Stone GW, Maehara A, Lansky AJ, et al. A prospective naturalhistory study of coronary atherosclerosis. N Engl J Med 2011;364(3): 226-35.
2. Stone PH, Saito S, Takahashi S, et al. Prediction of progression of coronary artery disease and clinical outcomes using vascular profiling of endothelial shear stress and arterial plaque characteristics: The PREDICTION Study. Circulation 2012;126(2):172-81.
3. Calvert PA, Obaid DR, O'Sullivan M, et al. Association between IVUS findings and adverse outcomes in patients with coronary artery disease: The VIVA (VH-IVUS in Vulnerable Atherosclerosis) Study. JACC Cardiovasc Imaging 2011;4(8):894-901.
4. Wykrzykowska JJ, Diletti R, Gutierrez-Chico JL, et al. Plaque sealing and passivation with a mechanical self-expanding low outward force nitinol vShield device for the treatment of IVUS and OCT-derived thin cap fibroatheromas (TCFAs) in native coronary arteries: Report of the pilot study vShield Evaluated at Cardiac hospital in Rotterdam for Investigation and Treatment of TCFA (SECRITT). EuroIntervention 2012;8:945-54.
5. Kragel AH, Reddy SG, Wittes JT, et al. Morphometric analysis of the composition of atherosclerotic plaques in the four major epicardial coronary arteries in acute myocardial infarction and in sudden coronary death. Circulation 1989;80(6):1747-56.
6. Moreno PR, Bernardi VH, Lopez-Cuellar J, et al. Macrophages, smooth muscle cells, and tissue factor in unstable angina. Implications for cell-mediated thrombogenicity in acute coronary syndromes. Circulation 1996;94(12):3090-7.
7. Burke AP, Farb A, Malcom GT, et al. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 1997;336(18):1276-82.
8. Ehara S, Kobayashi Y, Yoshiyama M, et al. Coronary artery calcification revisited. J Atheroscler Thromb 2006;13(1):31-7.
9. Virmani R, Kolodgie FD, Burke AP, et al. Atherosclerotic plaque progression and vulnerability to rupture: Angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 2005; 25(10):2054-61.
10. Garcia-Garcia HM, Mintz GS, Lerman A, et al. Tissue characterisation using intravascular radiofrequency data analysis: Recommendations for acquisition, analysis, interpretation and reporting. EuroIntervention 2009;5(2):177-89.
11. Marso SP, Frutkin AD, Mehta SK, et al. Intravascular ultrasound measures of coronary atherosclerosis are associated with the Framingham risk score: An analysis from a global IVUS registry. EuroIntervention 2009;5(2):212-8.
12. Serruys PW, Garcia-Garcia HM, Buszman P, et al. Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque. Circulation 2008;118(11): 1172-82.
13. Kubo T, Maehara A, Mintz GS, et al. The dynamic nature of coronary artery lesion morphology assessed by serial virtual histology intravascular ultrasound tissue characterization. J Am Coll Cardiol 2010;55(15):1590-7.
14. Thim T, Hagensen MK, Wallace-Bradley D, et al. Unreliable assessment of necrotic core by virtual histology intravascular ultrasound in porcine coronary artery disease. Circ Cardiovasc Imaging 2010;3(4):384-91.
15. Tearney GJ, Regar E, Akasaka T, et al. Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: A report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation. J Am Coll Cardiol 2012;59(12): 1058-72.
16. Kang SJ, Mintz GS, Akasaka T, et al. Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation. Circulation 2011;123(25):2954-63.
17. Fujii K, Kawasaki D, Masutani M, et al. OCT assessment of thin-cap fibroatheroma distribution in native coronary arteries. JACC Cardiovasc Imaging 2010;3(2):168-75.
18. Gonzalo N, Garcia-Garcia HM, Regar E, et al. In vivo assessment of high-risk coronary plaques at bifurcations with combined intravascular ultrasound and optical coherence tomography. JACC Cardiovasc Imaging 2009;2(4):473-82.
19. Sawada T, Shite J, Garcia-Garcia HM, et al. Feasibility of combined use of intravascular ultrasound radiofrequency data analysis and optical coherence tomography for detecting thin-cap fibroatheroma. Eur Heart J 2008;29(9):1136-46.
20. Giattina SD, Courtney BK, Herz PR, et al. Assessment of coronary plaque collagen with polarization sensitive optical coherence tomography (PS-OCT). Int J Cardiol 2006;107(3):400-9.
21. Liu L, Gardecki JA, Nadkarni SK, et al. Imaging the subcellular structure of human coronary atherosclerosis using micro-optical coherence tomography. Nat Med 2011;17(8):1010-4.
22. Simsek C, Garcia-Garcia HM, van Geuns RJ, et al. The ability of high dosage rosuvastatin to improve plaque composition and decrease necrotic core in non-intervened coronary arteries: Rationale and design of the integrated biomarker and imaging study-3 (IBIS-3). EuroIntervention 2012;8:235-41.
23. Karpiouk AB, Wang B, Emelianov SY. Development of a catheter for combined intravascular ultrasound and photoacoustic imaging. Rev Sci Instrum 2010;81(1):014901.
24. Li BH, Leung AS, Soong A, et al. Hybrid intravascular ultrasound and optical coherence tomography catheter for imaging of coronary atherosclerosis. Catheter Cardiovasc Interv 2013;81: 494-507.
25. Stephens DN, Park J, Sun Y, et al. Intraluminal fluorescence spectroscopy catheter with ultrasound guidance. J Biomed Opt 2009; 14(3):030505.
26. Papadopoulou SL, Neefjes LA, Schaap M, et al. Detection and quantification of coronary atherosclerotic plaque by 64-slice multidetector CT: A systematic head-to-head comparison with intravascular ultrasound. Atherosclerosis 2011;219(1):163-70.
27. Gauss S, Achenbach S, Pflederer T, et al. Assessment of coronary artery remodelling by dual-source CT: A head-to-head comparison with intravascular ultrasound. Heart 2011;97(12):991-7.
28. Voros S, Rinehart S, Qian Z, et al. Prospective validation of standardized, 3-dimensional, quantitative coronary computed tomographic plaque measurements using radiofrequency backscatter intravascular ultrasound as reference standard in intermediate coronary arterial lesions: Results from the ATLANTA (assessment of tissue characteristics, lesion morphology, and hemodynamics by angiography with fractional flow reserve, intravascular ultrasound and virtual histology, and noninvasive computed tomography in atherosclerotic plaques) I study. JACC Cardiovasc Interv 2011;4(2): 198-208.
29. Motoyama S, Sarai M, Harigaya H, et al. Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. J Am Coll Cardiol 2009;54(1): 49-57.
30. Villines TC, Hulten EA, Shaw LJ, et al. Prevalence and severity of coronary artery disease and adverse events among symptomatic patients with coronary artery calcification scores of zero undergoing coronary computed tomography angiography: Results from the CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter) registry. J Am Coll Cardiol 2011;58(24):2533-40.
31. Muntendam P, McCall C, Sanz J, et al. The BioImage Study: Novel approaches to risk assessment in the primary prevention of atherosclerotic cardiovascular disease-study design and objectives. Am Heart J 2010;160(1):49e1-57e1.
32. Corti R, Fuster V. Imaging of atherosclerosis: Magnetic resonance imaging. Eur Heart J 2011;32(14):1709-1719b.
33. Mach F, Schonbeck U, Bonnefoy JY, et al. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: Induction of collagenase, stromelysin, and tissue factor. Circulation 1997;96(2):396-9.
34. Amento EP, Ehsani N, Palmer H, et al. Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arterioscler Thromb 1991;11(5):1223-30.
35. Rzeszutko L, Legutko J, Kaluza GL, et al. Assessment of culprit plaque temperature by intracoronary thermography appears inconclusive in patients with acute coronary syndromes. Arterioscler Thromb Vasc Biol 2006;26(8):1889-94.
36. Stefanadis C, Diamantopoulos L, Vlachopoulos C, et al. Thermal heterogeneity within human atherosclerotic coronary arteries detected in vivo: A new method of detection by application of a special thermography catheter. Circulation 1999;99(15):1965-71.
37. Jaffer FA, Calfon MA, Rosenthal A, et al. Two-dimensional intravascular near-infrared fluorescence molecular imaging of inflammation in atherosclerosis and stent-induced vascular injury. J Am Coll Cardiol 2011;57(25):2516-26.
38. Yoo H, Kim JW, Shishkov M, et al. Intra-arterial catheter for simultaneous microstructural and molecular imaging in vivo. Nat Med 2011;17(12):1680-4.
39. Tearney GJ, Yabushita H, Houser SL, et al. Quantification of macrophage content in atherosclerotic plaques by optical coherence tomography. Circulation 2003;107(1):113-9.
40. Tawakol A, Migrino RQ, Bashian GG, et al. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol 2006;48(9):1818-24.
41. Rogers IS, Nasir K, Figueroa AL, et al. Feasibility of FDG imaging of the coronary arteries: Comparison between acute coronary syndrome and stable angina. JACC Cardiovasc Imaging 2010;3(4):388-97.
42. Wykrzykowska J, Lehman S, Williams G, et al. Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation. J Nucl Med 2009;50(4): 563-8.
43. Fujimoto S, Hartung D, Ohshima S, et al. Molecular imaging of matrix metalloproteinase in atherosclerotic lesions: Resolution with dietary modification and statin therapy. J Am Coll Cardiol 2008;52(23): 1847-57.
44. Kietselaer BL, Reutelingsperger CP, Heidendal GA, et al. Noninvasive detection of plaque instability with use of radiolabeled annexin A5 in patients with carotid-artery atherosclerosis. N Engl J Med 2004; 350(14):1472-3.
45. Tsimikas S. Noninvasive imaging of oxidized low-density lipoprotein in atherosclerotic plaques with tagged oxidation-specific antibodies. Am J Cardiol 2002;90(10C):22L-7L.
46. Hyafil F, Cornily JC, Feig JE, et al. Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography. Nat Med 2007;13(5):636-41.
47. Hyafil F, Cornily JC, Rudd JH, et al. Quantification of inflammation within rabbit atherosclerotic plaques using the macrophage-specific CT contrast agent N1177: A comparison with 18F-FDG PET/CT and histology. J Nucl Med 2009;50(6):959-65.
48. Caro CG, Fitz-Gerald JM, Schroter RC. Arterial wall shear and distribution of early atheroma in man. Nature 1969;223(5211): 1159-60.
49. Samady H, Eshtehardi P, McDaniel MC, et al. Coronary artery wall shear stress is associated with progression and transformation of atherosclerotic plaque and arterial remodeling in patients with coronary artery disease. Circulation 2011;124(7):779-88.
50. Wentzel JJ, Krams R, Schuurbiers JC, et al. Relationship between neointimal thickness and shear stress after Wallstent implantation in human coronary arteries. Circulation 2001;103(13):1740-5.
51. Stone PH, Coskun AU, Kinlay S, et al. Regions of low endothelial shear stress are the sites where coronary plaque progresses and vascular remodelling occurs in humans: An in vivo serial study. Eur Heart J 2007;28(6):705-10.
52. Bourantas CV, Papafaklis MI, Naka KK, et al. Fusion of optical coherence tomography and coronary angiography-in vivo assessment of shear stress in plaque rupture. Int J Cardiol 2012; 155(2):e24-6.
53. Fukumoto Y, Hiro T, Fujii T, et al. Localized elevation of shear stress is related to coronary plaque rupture: A 3-dimensional intravascular ultrasound study with in-vivo color mapping of shear stress distribution. J Am Coll Cardiol 2008;51(6):645-50.
54. Slager CJ, Wentzel JJ, Gijsen FJ, et al. The role of shear stress in the destabilization of vulnerable plaques and related therapeutic implications. Nat Clin Pract Cardiovasc Med 2005;2(9): 456-64.
55. Goubergrits L, Kertzscher U, Schoneberg B, et al. CFD analysis in an anatomically realistic coronary artery model based on non-invasive 3D imaging: Comparison of magnetic resonance imaging with computed tomography. Int J Cardiovasc Imaging 2008;24(4): 411-21.
56. van der Giessen AG, Wentzel JJ, Meijboom WB, et al. Plaque and shear stress distribution in human coronary bifurcations: A multislice computed tomography study. EuroIntervention 2009;4(5):654-61.
57. Brennan ML, Reddy A, Tang WH, et al. Comprehensive peroxidasebased hematologic profiling for the prediction of 1-year myocardial infarction and death. Circulation 2010;122(1):70-9.
58. Elesber AA, Conover CA, Denktas AE, et al. Prognostic value of circulating pregnancy-associated plasma protein levels in patients with chronic stable angina. Eur Heart J 2006;27(14):1678-84.
59. Prins BP, Lagou V, Asselbergs FW, Snieder H, Fu J. Genetics of coronary artery disease: Genome-wide association studies and beyond. Atherosclerosis 2012;225:1-10.
60. Thompson A, Gao P, Orfei L, et al. Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: Collaborative analysis of 32 prospective studies. Lancet 2010;375(9725):1536-44.
61. Maehara A, Mintz GS, Bui AB, et al. Morphologic and angiographic features of coronary plaque rupture detected by intravascular ultrasound. J Am Coll Cardiol 2002;40(5):904-10.
62. Tanaka A, Imanishi T, Kitabata H, et al. Distribution and frequency of thin-capped fibroatheromas and ruptured plaques in the entire culprit coronary artery in patients with acute coronary syndrome as determined by optical coherence tomography. Am J Cardiol 2008; 102(8):975-9.
63. Rioufol G, Gilard M, Finet G, et al. Evolution of spontaneous atherosclerotic plaque rupture with medical therapy: Long-term follow-up with intravascular ultrasound. Circulation 2004;110(18): 2875-80.
64. Fujii K, Kobayashi Y, Mintz GS, et al. Intravascular ultrasound assessment of ulcerated ruptured plaques: A comparison of culprit and nonculprit lesions of patients with acute coronary syndromes and lesions in patients without acute coronary syndromes. Circulation 2003;108(20):2473-8.
65. Cecchi E, Liotta AA, Gori AM, et al. Comparison of hemorheological variables in ST-elevation myocardial infarction versus those in non-ST-elevation myocardial infarction or unstable angina pectoris. Am J Cardiol 2008;102(2):125-8.
66. Smyth SS, Monroe III DM, Wysokinski WE, et al. Platelet activation and its patient-specific consequences. Thromb Res 2008;122(4): 435-41.
67. Spiel AO, Gilbert JC, Jilma B. von Willebrand factor in cardiovascular disease: Focus on acute coronary syndromes. Circulation 2008;117(11):1449-59.
68. Farb A, Burke AP, Tang AL, et al. Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. Circulation 1996;93(7): 1354-63.
69. Mercado N, Maier W, Boersma E, et al. Clinical and angiographic outcome of patients with mild coronary lesions treated with balloon angioplasty or coronary stenting. Implications for mechanical plaque sealing. Eur Heart J 2003;24(6):541-51.
70. Serruys PW, Garcia-Garcia HM, Onuma Y. From metallic cages to transient bioresorbable scaffolds: Change in paradigm of coronary revascularization in the upcoming decade? Eur Heart J 2012;33(1): 16-25b.
71. Onuma Y, Serruys PW, Perkins LE, et al. Intracoronary optical coherence tomography and histology at 1 month and 2, 3, and 4 years after implantation of everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: An attempt to decipher the human optical coherence tomography images in the ABSORB trial. Circulation 2010;122(22):2288-300.
72. Brugaletta S, Radu MD, Garcia-Garcia HM, et al. Circumferential evaluation of the neointima by optical coherence tomography after ABSORB bioresorbable vascular scaffold implantation: Can the scaffold cap the plaque? Atherosclerosis 2012;221(1):106-12.
73. Moreno PR. Vulnerable plaque: Definition, diagnosis, and treatment. Cardiol Clin 2010;28(1):1-30.
74. Raber L, Heo JH, Radu MD, et al. Offline fusion of co-registered intravascular ultrasound and frequency domain optical coherence tomography images for the analysis of human atherosclerotic plaques. EuroIntervention 2012;8(1):98-108.
75. Wang B, Su JL, Amirian J, et al. Detection of lipid in atherosclerotic vessels using ultrasound-guided spectroscopic intravascular photoacoustic imaging. Opt Express 2010;18(5):4889-97.
76. Bourantas CV, Kalatzis FG, Papafaklis MI, et al. ANGIOCARE: An automated system for fast three-dimensional coronary reconstruction by integrating angiographic and intracoronary ultrasound data. Catheter Cardiovasc Interv 2008;72(2):166-75.
77. Wentzel JJ, van der Giessen AG, Garg S, et al. In vivo 3D distribution of lipid-core plaque in human coronary artery as assessed by fusion of near infrared spectroscopy-intravascular ultrasound and multislice computed tomography scan. Circ Cardiovasc Imaging 2010;3(6):e6-7.
78. Bourantas CV, Papafaklis MI, Garcia-Garcia HM, et al. Short-and long-term implications of a bioresorbable vascular scaffold implantation on the local endothelial shear stress patterns. JACC Cardiovasc Interv 2013 In press.
79. Kubo T, Nakamura N, Matsuo Y, et al. Virtual histology intravascular ultrasound compared with optical coherence tomography for identification of thin-cap fibroatheroma. Int Heart J 2011;52:175-9.
80. Kawasaki M, Bouma BE, Bressner J, et al. Diagnostic accuracy of optical coherence tomography and integrated backscatter intravascular ultrasound images for tissue characterization of human coronary plaques. J Am Coll Cardiol 2006;48:81-8.
81. Garcia-Garcia HM, Costa MA, Serruys PW. Imaging of coronary atherosclerosis: Intravascular ultrasound. Eur Heart J 2010;31: 2456-69.
82. Ohtani T, Ueda Y, Mizote I, et al. Number of yellow plaques detected in a coronary artery is associated with future risk of acute coronary syndrome: Detection of vulnerable patients by angioscopy. J Am Coll Cardiol 2006;47:2194-200.
83. Schneiderman J, Wilensky RL, Weiss A, et al. Diagnosis of thin-cap fibroatheromas by a self-contained intravascular magnetic resonance imaging probe in ex vivo human aortas and in situ coronary arteries. J Am Coll Cardiol 2005;45:1961-9.
84. Gardner CM, Tan H, Hull EL, et al. Detection of lipid core coronary plaques in autopsy specimens with a novel catheter-based nearinfrared spectroscopy system. JACC Cardiovasc Imaging 2008;1: 638-48.
85. Sathyanarayana S, Schar M, Kraitchman DL, et al. Towards real-time intravascular endoscopic magnetic resonance imaging. JACC Cardiovasc Imaging 2010;3:1158-65.
86. Wang B, Karpiouk A, Yeager D, Amirian J, et al. In vivo intravascular ultrasound-guided photoacoustic imaging of lipid in plaques using an animal model of atherosclerosis. Ultrasound Med Biol 2012;38: 2098-103.
87. Wang B, Su JL, Karpiouk AB, et al. Intravascular photoacoustic imaging. IEEE J Quantum Electron 2010;16:588-99.
88. Marcu L. Fluorescence lifetime in cardiovascular diagnostics. J Biomed Opt 2010;15:011106.
89. Jaffer FA, Vinegoni C, John MC, et al. Real-time catheter molecular sensing of inflammation in proteolytically active atherosclerosis. Circulation 2008;118:1802-9.
90. Lev EI, Kornowski R, Vaknin-Assa H, et al. Comparison of the predictive value of four different risk scores for outcomes of patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol 2008;102:6-11.
91. SimmsAD, Reynolds S, Pieper K, et al. Evaluation of theNICEmini-GRACE risk scores for acute myocardial infarction using the Myocardial Ischaemia National Audit Project (MINAP) 2003-2009: National Institute for Cardiovascular Outcomes Research (NICOR). Heart 2013;99:35-40.
92. Palmerini T, Caixeta A, Genereux P, et al. Comparison of clinical and angiographic prognostic risk scores in patientswith acute coronary syndromes: Analysis from the Acute Catheterization and Urgent Intervention Triage Strateg Y(ACUITY)trial.AmHeartJ2012;163:383-91.
93. Garg S, SarnoG, Serruys PW, et al. Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: A substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials. JACC Cardiovasc Interv 2011;4:66-75.
94. Genereux P, Palmerini T, Caixeta A, et al. Quantification and impact of untreated coronary artery disease after percutaneous coronary intervention: The residual SYNTAX (Synergy Between PCI with Taxus and Cardiac Surgery) score. J Am Coll Cardiol 2012;59:2165-74.
95. Girasis C, Garg S, Raber L, et al. SYNTAX score and Clinical SYNTAX score as predictors of very long-term clinical outcomes in patients undergoing percutaneous coronary interventions: A substudy of SIRolimus-eluting stent compared with pacliTAXel-eluting stent for coronary revascularization (SIRTAX) trial. Eur Heart J 2011;32: 3115-27.
96. Garg S, Serruys PW, Silber S, et al. The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus-and everolimus-eluting stents: A substudy of the RESOLUTE All Comers Trial. JACC Cardiovasc Interv 2011;4:432-41.
97. Chiba N, Nagao K, Mukoyama T, et al. Decreased activated protein C levels as a clinical predictor in patients with ST-elevation myocardial infarction. Am Heart J 2008;156:931-8.
98. Damman P, Beijk MA, Kuijt WJ, et al. Multiple biomarkers at admission significantly improve the prediction of mortality in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. J Am Coll Cardiol 2011;57:29-36.
99. D'Agostino Sr RB, Grundy S, Sullivan LM, et al. Validation of the Framingham coronary heart disease prediction scores: Results of a multiple ethnic groups investigation. JAMA 2001;286:180-7.
100. McNeill AM, Rosamond WD, Girman CJ, et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 2005;28:385-90.
101. Conroy RM, Pyorala K, Fitzgerald AP, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: The SCORE project. Eur Heart J 2003;24:987-1003.
102. Woodward M, Brindle P, Tunstall-Pedoe H. Adding social deprivation and family history to cardiovascular risk assessment: The ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC). Heart 2007; 93:172-6.
103. Collins GS, Altman DG. An independent external validation and evaluation of QRISK cardiovascular risk prediction: A prospective open cohort study. BMJ 2009;339:b2584.
104. Wang TJ, Gona P, Larson MG, et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med 2006;355:2631-9.
105. Melander O, Newton-Cheh C, Almgren P, et al. Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. JAMA 2009;302:49-57.
106. Zethelius B, Berglund L, Sundstrom J, et al. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med 2008;358:2107-16.
107. Fowkes FG, Murray GD, Butcher I, et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: A meta-analysis. JAMA 2008;300:197-208.
108. Arad Y, Goodman KJ, Roth M, et al. Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: The St. Francis Heart Study. J Am Coll Cardiol 2005;46:158-65.
109. Detrano R, Guerci AD, Carr JJ, et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med 2008; 358:1336-45.
110. Morrison AC, Bare LA, Chambless LE, et al. Prediction of coronary heart disease risk using a genetic risk score: The Atherosclerosis Risk in Communities Study. Am J Epidemiol 2007;166:28-35.
111. Brautbar A, Pompeii LA, Dehghan A, et al. A genetic risk score based on direct associations with coronary heart disease improves coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC), but not in the Rotterdam and Framingham Offspring, Studies. Atherosclerosis 2012;223:421-6.
112. Talmud PJ, Cooper JA, Palmen J, et al. Chromosome 9p21.3 coronary heart disease locus genotype and prospective risk of CHD in healthy middle-aged men. Clin Chem 2008;54:467-74.